Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.

Sagan SM, Dupont B, Grebely J, Krajden M, MacParland SA, Raven JF, Saeed S, Feld JJ, Tyrrell DL, Wilson JA.

Can J Gastroenterol Hepatol. 2016;2016:5743521. doi: 10.1155/2016/5743521. Epub 2016 Apr 27.

2.

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

Chin JL, Pavlides M, Moolla A, Ryan JD.

Front Pharmacol. 2016 Jun 20;7:159. doi: 10.3389/fphar.2016.00159. eCollection 2016. Review.

3.

Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease.

Lucero C, Brown RS Jr.

Gastroenterol Hepatol (N Y). 2016 Jan;12(1):33-40.

4.

T2 relaxation time is related to liver fibrosis severity.

Guimaraes AR, Siqueira L, Uppal R, Alford J, Fuchs BC, Yamada S, Tanabe K, Chung RT, Lauwers G, Chew ML, Boland GW, Sahani DV, Vangel M, Hahn PF, Caravan P.

Quant Imaging Med Surg. 2016 Apr;6(2):103-14. doi: 10.21037/qims.2016.03.02.

5.

Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.

Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC; Womenʼs Interagency HIV Study Protocol Team.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):266-73. doi: 10.1097/QAI.0000000000000957.

PMID:
26885801
6.

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.

Solomon SS, Srikrishnan AK, McFall AM, Kumar MS, Saravanan S, Balakrishnan P, Solomon S, Thomas DL, Sulkowski MS, Mehta SH.

PLoS One. 2016 Jan 26;11(1):e0147879. doi: 10.1371/journal.pone.0147879. eCollection 2016.

7.

Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.

Thavorn K, Coyle D.

Ont Health Technol Assess Ser. 2015 Nov 1;15(19):1-58. eCollection 2015. Review.

8.

Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.

Brener S.

Ont Health Technol Assess Ser. 2015 Nov 1;15(18):1-45. eCollection 2015. Review.

9.

Personalized management of cirrhosis by non-invasive tests of liver fibrosis.

Wong GL, Espinosa WZ, Wong VW.

Clin Mol Hepatol. 2015 Sep;21(3):200-11. doi: 10.3350/cmh.2015.21.3.200. Epub 2015 Sep 30. Review.

10.

MR Elastography of Liver Disease: State of the Art.

Chen J, Yin M, Glaser KJ, Talwalkar JA, Ehman RL.

Appl Radiol. 2013 Apr;42(4):5-12. No abstract available.

11.

Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and Opinion.

Expert Panel on Liver Stiffness Measurement.

J Clin Transl Hepatol. 2014 Jun;2(2):110-6. doi: 10.14218/JCTH.2014.00008. Epub 2014 Jun 15. Review.

12.

Quantification of liver fibrosis in chronic hepatitis B virus infection.

Jieanu CF, Ungureanu BS, Săndulescu DL, Gheonea IA, Tudorașcu DR, Ciurea ME, Purcărea VL.

J Med Life. 2015 Jul-Sep;8(3):285-90. Review.

13.

Direct and Indirect Serum Markers of Liver Fibrosis Compared with Transient Elastography among Women in the Women's Interagency HIV Study.

Kassaye S, Li Y, Huhn G, Peters MG, French AL, Tien PC, Luxon B, Plankey MW.

J AIDS Clin Res. 2015 Apr;6(4). pii: 446.

14.

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.

Kohli A, Kapoor R, Sims Z, Nelson A, Sidharthan S, Lam B, Silk R, Kotb C, Gross C, Teferi G, Sugarman K, Pang PS, Osinusi A, Polis MA, Rustgi V, Masur H, Kottilil S.

Lancet Infect Dis. 2015 Sep;15(9):1049-54. doi: 10.1016/S1473-3099(15)00157-7. Epub 2015 Jul 14.

15.

FibroScan® access in Canada: Time for reform, a call for universal access.

Borgia SM.

Can J Gastroenterol Hepatol. 2015 May;29(4):221-2. No abstract available.

16.

Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

Sadler MD, Crotty P, Fatovich L, Wilson S, Rabin HR, Myers RP.

Can J Gastroenterol Hepatol. 2015 Apr;29(3):139-44.

17.

Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia.

Kan VY, Marquez Azalgara V, Ford JA, Peter Kwan WC, Erb SR, Yoshida EM.

Can J Gastroenterol Hepatol. 2015 Mar;29(2):72-6.

18.

Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Arora A, Sharma P.

J Clin Exp Hepatol. 2012 Jun;2(2):145-55. doi: 10.1016/S0973-6883(12)60103-0. Epub 2012 Jul 21.

19.

Hepatitis C and kidney disease: An overview and approach to management.

Azmi AN, Tan SS, Mohamed R.

World J Hepatol. 2015 Jan 27;7(1):78-92. doi: 10.4254/wjh.v7.i1.78. Review.

20.

Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.

Al-Anazi MR, Matou-Nasri S, Abdo AA, Sanai FM, Khan MQ, Albenmousa A, Al-Ashgar HI, Khalaf NZ, Al-Ahdal MN, Al-Qahtani AA.

BMC Infect Dis. 2014 Dec 31;14:632. doi: 10.1186/s12879-014-0632-y.

Items per page

Supplemental Content

Write to the Help Desk